REGN: Regeneron Pharmaceuticals Inc
REGN exchange rate has changed by 0.45% for today. During the day, the instrument was traded at a low of 666.88 and at a high of 678.67.
Follow Regeneron Pharmaceuticals Inc dynamics. Real-time quotes will help you quickly react to market changes. By switching between different timeframes, you can monitor exchange rate trends and dynamics by minutes, hours, days, weeks, and months. Use this information to forecast market changes and to make informed trading decisions.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
REGN News
- 4D Molecular: 'Buy' Wet-AMD Study Readouts 2027 And DME Expansion Opportunity (FDMT)
- Stock Market Losses Led By Nasdaq, AI Stocks; Goldman, GE, Taiwan Semi, IBM In Focus: Weekly Review
- Merck Snags A First-Of-Its-Kind Approval, And Shares Jump
- Longleaf Partners Global Fund Q2 2026 Portfolio Review
- Baird International And Global Growth Funds Q2 2026 Contributors And Detractors
- These biggest and ‘least loved’ stocks are the ones to pick ahead of earnings
- Why Investors Need to Take Advantage of These 2 Medical Stocks Now
- Novo Nordisk's Wegovy Pill Escalates Eli Lilly Rivalry (NYSE:NVO)
- Will Regeneron (REGN) Beat Estimates Again in Its Next Earnings Report?
- Here's Why Regeneron (REGN) is a Strong Value Stock
- These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
- Can Alnylam's Drug Pipeline Fuel Its Long-Term Revenue Growth?
- Why Regeneron (REGN) is a Top Momentum Stock for the Long-Term
- What Sparked the $43B Jump in AbbVie's Market Cap in the Past Week?
- Big Pharma's Looming Patent Cliff Period And How It Is Trying To Address It (NYSEARCA:XLV)
- Healthcare stocks have become a haven for investors ditching tech
- Here's Why You Should Add Kiniksa Stock to Your Portfolio Now
- BAYRY Stock Surges 17% After Supreme Court Roundup Ruling
- Beam Therapeutics: A Better Entry Point Is Likely Coming (Rating Downgrade) (NASDAQ:BEAM)
- Is Kymera Therapeutics The Next Big Rival To Regeneron And Sanofi?
- Biotech Kiniksa Pushes Toward A Buy Zone With Blockbuster Drug Sales In View
- Regeneron's Applications for gMG Drug Accepted by FDA and EMA
- Viatris Soared 54%: Time To Be More Careful (Rating Downgrade) (NASDAQ:VTRS)
- ABBV Jumps on Deepening Immunology Portfolio With $10.9B APGE Buyout
Frequently Asked Questions
What is REGN stock price today?
Regeneron Pharmaceuticals Inc stock is priced at 675.19 today. It trades within 666.88 - 678.67, yesterday's close was 672.15, and trading volume reached 2224. The live price chart of REGN shows these updates.
Does Regeneron Pharmaceuticals Inc stock pay dividends?
Regeneron Pharmaceuticals Inc is currently valued at 675.19. Dividend policy depends on the company, while investors also watch 15.81% and USD. View the chart live to track REGN movements.
How to buy REGN stock?
You can buy Regeneron Pharmaceuticals Inc shares at the current price of 675.19. Orders are usually placed near 675.19 or 675.49, while 2224 and 0.39% show market activity. Follow REGN updates on the live chart today.
How to invest into REGN stock?
Investing in Regeneron Pharmaceuticals Inc involves considering the yearly range 541.00 - 821.11 and current price 675.19. Many compare 7.26% and -8.01% before placing orders at 675.19 or 675.49. Explore the REGN price chart live with daily changes.
What are Regeneron Pharmaceuticals Inc stock highest prices?
The highest price of Regeneron Pharmaceuticals Inc in the past year was 821.11. Within 541.00 - 821.11, the stock fluctuated notably, and comparing with 672.15 helps spot resistance levels. Track Regeneron Pharmaceuticals Inc performance using the live chart.
What are Regeneron Pharmaceuticals Inc stock lowest prices?
The lowest price of Regeneron Pharmaceuticals Inc (REGN) over the year was 541.00. Comparing it with the current 675.19 and 541.00 - 821.11 shows potential long-term entry points. Watch REGN moves on the chart live for more details.
When did REGN stock split?
Regeneron Pharmaceuticals Inc has gone through stock splits historically. These changes are visible in , 672.15, and 15.81% after corporate actions.
- Previous Close
- 672.15
- Open
- 672.55
- Bid
- 675.19
- Ask
- 675.49
- Low
- 666.88
- High
- 678.67
- Volume
- 2.224 K
- Daily Change
- 0.45%
- Month Change
- 7.26%
- 6 Months Change
- -8.01%
- Year Change
- 15.81%
- Act
- Fcst
- 1.978 M
- Prev
- -1.692 M
- Act
- Fcst
- 0.992 M
- Prev
- 0.430 M
- Act
- Fcst
- Prev
- 4.927%